Dhanuka Agritech Limited (507717) Earnings Call Transcripts

26 earnings calls from February 2020 to August 3, 2026

BSE IN Materials Chemicals

Dhanuka Agritech Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '25-'26, Dhanuka Agritech Limited reported a revenue of INR 48.3 crores, up 9% year-over-year from INR 42.02 crores, and a profit after tax of INR 97.7 crores, reflecting a significant increase from INR 75.5 crores in the prior year. The company also announced a dividend of INR 2 per share and a buyback of up to 5 lakh shares at INR 1,400 each, signaling confidence in its financial health. Management maintained a cautious outlook for FY '27, projecting low double-digit growth while acknowledging challenges from climatic conditions and geopolitical factors affecting the agrochemical sector.

Reported metrics

MetricValueContext
Revenue INR 48.3 crores (beat) vs INR 42.02 crores in Q4 FY '24-'25, +9% YoY
EBITDA INR 124.9 crores (beat) vs INR 109.7 crores in Q4 FY '24-'25
Profit After Tax INR 97.7 crores (beat) vs INR 75.5 crores in Q4 FY '24-'25
Dividend INR 2 per share (positive) 100% dividend declared
Buyback Amount INR 70 crores (positive) for up to 5 lakh shares at INR 1,400 each
Dahej Revenue INR 50 crores (beat) vs INR 41 crores in FY '25-'26

Guidance from management

Management expects low double-digit growth for FY '27, with contributions from new product introductions and recovery from previous bans. They acknowledged potential challenges from GST refunds and economic benefits impacting performance.

What management said

Yes. So registration is not the bigger issue because the major concern is around appointing the distributors and managing the supply chain. With the support of Bayer AG, we are resolving most of the issues on how the supply chain will be handled in the coming times. We have already initiated the formulation of both the Melody Duo variants in India. Triadimenol formulation will also be shifting to India in current ...
— Mahendra Dhanuka, Q4 FY2026 earnings call
So you see you asked 3, 4 questions in one question. You see one with regard to the EBITDA margin, -- this is largely because of the GST refund. You see in Udhampur unit, the GST refund year was last year, March '26 only. So you see the refund has increased significantly in the Q4 of this financial year because of which the EBITDA is highest in this quarter. In terms of the placement, placement is similar to the prev...
— Unknown Executive, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of channel inventory on future sales, particularly in light of lower pest infestations during the rabi season. There were also questions about the sustainability of margins amid rising input costs and the effectiveness of passing these costs onto customers.

Main topics on the call

Read the full Dhanuka Agritech Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Dhanuka Agritech Limited

Dhanuka Agritech Limited (507717) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 26 calls on record spanning February 13, 2020 to August 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 26 Dhanuka Agritech Limited earnings call transcripts on record, spanning February 13, 2020 to August 3, 2026. Based on this history, Dhanuka Agritech Limited reports quarterly. The most recent call on file is dated August 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
507717
Exchange
BSE
Country
IN
Sector
Materials
Industry
Chemicals
Calls on record
26
First call
February 13, 2020
Most recent
August 3, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Aug 3, 2026 Read transcript
Q4 FY2026 May 19, 2026 Read transcript
Q3 FY2026 Feb 5, 2026 Read transcript
Q4 FY2025 May 16, 2025 Read transcript
Q3 FY2025 Feb 3, 2025 Read transcript
M&A Calls Dec 23, 2024 Read transcript
Q2 FY2025 Nov 6, 2024 Read transcript
Q1 FY2025 Aug 2, 2024 Read transcript
Q4 FY2024 May 17, 2024 Read transcript
Q3 FY2024 Feb 2, 2024 Read transcript
Q2 FY2024 Nov 7, 2023 Read transcript
Q1 FY2024 Aug 2, 2023 Read transcript
Q4 FY2023 May 25, 2023 Read transcript
Q2 FY2023 Nov 1, 2022 Read transcript
Q1 FY2023 Aug 2, 2022 Read transcript
Q4 FY2022 May 23, 2022 Read transcript
Q3 FY2022 Feb 2, 2022 Read transcript
Q2 FY2022 Oct 30, 2021 Read transcript
Q1 FY2022 Jul 30, 2021 Read transcript
Q4 FY2021 May 21, 2021 Read transcript
Q3 FY2021 Feb 2, 2021 Read transcript
Q2 FY2021 Oct 30, 2020 Read transcript
Q1 FY2021 Jul 22, 2020 Read transcript
Q4 FY2020 Jun 10, 2020 Read transcript
Shareholder/Analyst Calls Apr 1, 2020 Read transcript
Q3 FY2020 Feb 13, 2020 Read transcript